• Noven Pharm., Inc v. Actavis Lab. UT, Inc.

    Publication Date: 2018-01-17
    Practice Area: Patent Litigation
    Industry: Pharmaceuticals
    Court: U.S. District Court of Delaware
    Judge: District Judge Stark
    Attorneys: For plaintiff: Jack B. Blumenfeld and Stephen J. Kraftschik, Morris, Nichols Arsht & Tunnell LLP, Wilmington, DE; Liane M. Peterson and Ryan A. Schmid, Foley & Lardner LLP, Washington, DE; Steven J. Rizzi, Ramy E. Hanna, and Jayita Guhaniyogi, Foley & Lardner LLP, New York NY; Rebecca J. Pirozzolo-Mellowes, Foley & Lardner LLP, Milwaukee, WI, attorneys for plaintiff and third-party defendant
    for defendant: Steven J. Fineman and Katharine L. Mowery, Richards, Layton & Finger P.A., Wilmington, DE; James K. Stronski, Jacob Z. Zambrizycki, Anne E.H. Li, and Preetha Chakrabarti, Crowell & Moring LLP, New York, NY; Chiemi D. Suzuki, Crowell & Moring LLP, Los Angeles, CA; Craig P. Lytle, Crowell & Moring LLP, Washington, DC, attorneys for defendant.

    Case Number: D68008

    Plaintiff was barred by prosecution history estoppel from asserting infringement under doctrine of equivalents where limitation amended to claim was added specifically in response to reject to distinguish claim from prior art.